2022 - What Clinical Trial Participants Want — And How Sponsors can Deliver
Date2022-10-26
Deadline2022-10-26
VenueWebinar, USA - United States
KeywordsClinical Trial Design; Patient Participation; Patient Experience
Topics/Call fo Papers
What is the optimal clinical trial design? What do patients want when considering a clinical trial? The optimal trial design is not a one-size-fits-all approach. It is a series of countless permutations and protocol designs that must be carefully tailored to deliver the best trial for the patient and the sponsor.
In this webinar, Jon Meyer, Co-Founder of Life Science Strategy Group, will join Science 37’s Chief Strategy Officer, Drew Bustos to share survey results showing insights into what patients want with clinical trials now. Register now and discover:
The technologies that have the greatest, and most positive impact on participants
Which decentralized clinical trial elements are the top drivers of patient satisfaction
Why flexibility, convenience and at-home options are a must in clinical trial design
And, how to leverage an agile/hybrid approach to accelerate recruitment and improve patient diversity and retention
In this webinar, Jon Meyer, Co-Founder of Life Science Strategy Group, will join Science 37’s Chief Strategy Officer, Drew Bustos to share survey results showing insights into what patients want with clinical trials now. Register now and discover:
The technologies that have the greatest, and most positive impact on participants
Which decentralized clinical trial elements are the top drivers of patient satisfaction
Why flexibility, convenience and at-home options are a must in clinical trial design
And, how to leverage an agile/hybrid approach to accelerate recruitment and improve patient diversity and retention
Other CFPs
- The Strategic and Scientific Imperative for Prospectively Generated Real-World Evidence
- Reshaping Global ICSR Reporting to Deliver Real-Time Visibility and Oversight
- Placebo Response Mitigation Strategies & Tools for Optimizing Clinical Trials
- Leveraging Clinical Trial Ready IHC Assays from Target Validation to Prospective Enrollment and CDx Development
- Response Prediction in Oncology Clinical Trials
Last modified: 2022-10-05 02:40:26